# Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer

> **NCT01167725** · PHASE3 · TERMINATED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 340 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** bevacizumab
- **BIOLOGICAL:** cetuximab
- **DRUG:** FOLFIRI regimen
- **DRUG:** FOLFOX regimen
- **DRUG:** capecitabine
- **DRUG:** fluorouracil
- **DRUG:** irinotecan hydrochloride
- **DRUG:** leucovorin calcium
- **DRUG:** mitomycin C
- **DRUG:** oxaliplatin
- **PROCEDURE:** therapeutic conventional surgery

## Key facts

- **NCT ID:** NCT01167725
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-08
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2024-12-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01167725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01167725, "Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01167725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*